Dr. Timothy John Sullivan Iii, M.D. Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd., Ste 4640, Ogden, UT 84403 Phone: 801-387-4850 Fax: 801-387-4855 |
Vicki J Lyons, M.D. Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 4403 Harrison Blvd, Suite 4640, Ogden, UT 84403 Phone: 801-387-4850 Fax: 801-387-4855 |
Dr. Joseph Robert Anderson Jr., M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 5929 Fashion Point Dr, Suite 101, Ogden, UT 84403 Phone: 801-476-0052 Fax: 801-476-0064 |
Dr. Charles Mitchell Rogers, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 4403 Harrison Blvd Ste 4640, Ogden, UT 84403 Phone: 801-387-4850 |
News Archive
Accenture has completed its acquisition of Octagon Research Solutions, Inc., a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry based in Wayne, Pa. The acquisition was announced on Aug. 2.
The American Association of Clinical Endocrinologists (AACE) applauds the introduction of legislation in both the U.S. House of Representatives and the U.S. Senate that will preserve patient access to osteoporosis testing and treatment services under the Medicare program.
The ballot initiative would give the elected state insurance commissioner the power to regulate health insurance rates for small businesses and individuals. Proponents say it would make the rate-setting process more transparent. But a coalition of hospitals, doctors and health plans contend it would give too much power to one person.
When it comes to the cost and quality of hospital care, nurse tenure and teamwork matters. Patients get the best care when they are treated in units that are staffed by nurses who have extensive experience in their current job, according to a study from researchers at Columbia University School of Nursing and Columbia Business School.
Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today the enrollment of the first patient in Pivotal's POMEGA Phase IIa clinical trial with PVT-100.
› Verified 8 days ago